These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3602322)

  • 21. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
    Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P
    Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
    Lerner V; Kaptsan A; Miodownik C; Kotler M
    Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S; Debsikdar V
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia.
    Nevet A; Morris G; Saban G; Fainstein N; Bergman H
    J Neurophysiol; 2004 Oct; 92(4):1973-81. PubMed ID: 15115785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinsonism and tardive dyskinesia after chronic use of clebopride.
    Sempere AP; Duarte J; Palomares JM; Coria F; Clavería LE
    Mov Disord; 1994 Jan; 9(1):114-5. PubMed ID: 8166880
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Apomorphine in dyskinesia and psychomotor agitation].
    Stoliarov GV; Markova OF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(8):97-102. PubMed ID: 7136384
    [No Abstract]   [Full Text] [Related]  

  • 32. On the coexistence of parkinsonism and tardive dyskinesia.
    Fann WE; Lake CR
    Dis Nerv Syst; 1974 Jul; 35(7):324-6. PubMed ID: 17894090
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of tardive dyskinesia in affective disorder patients.
    Yassa R; Ghadirian AM; Schwartz G
    J Clin Psychiatry; 1983 Nov; 44(11):410-2. PubMed ID: 6139365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Improper treatment of patients with parkinsonism due to drug use].
    Meerwaldt JD; Staal A
    Ned Tijdschr Geneeskd; 1982 Jul; 126(28):1257-9. PubMed ID: 7133158
    [No Abstract]   [Full Text] [Related]  

  • 36. Akathisia in Parkinson's disease.
    Comella CL; Goetz CG
    Mov Disord; 1994 Sep; 9(5):545-9. PubMed ID: 7990849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems.
    Holcomb HH; Sternberg DE; Heninger GR
    Biol Psychiatry; 1983 Aug; 18(8):865-73. PubMed ID: 6615944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent parkinsonism and tardive dyskinesia induced by clebopride.
    Jiménez-Jiménez FJ; Cabrera-Valdivia F; Ayuso-Peralta L; Tejeiro J; Vaquero A; García-Albea E
    Mov Disord; 1993 Apr; 8(2):246-7. PubMed ID: 8474508
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME; Chevesich J; Lehrer E; Mosnaim AD
    Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.